| Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy HY Wang, DA Lee, G Peng, Z Guo, Y Li, Y Kiniwa, EM Shevach, RF Wang Immunity 20 (1), 107-118, 2004 | 701 | 2004 |
| Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells CJ Denman, VV Senyukov, SS Somanchi, PV Phatarpekar, LM Kopp, ... PloS one 7 (1), e30264, 2012 | 668 | 2012 |
| A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR H Torikai, A Reik, PQ Liu, Y Zhou, L Zhang, S Maiti, H Huls, JC Miller, ... Blood, The Journal of the American Society of Hematology 119 (24), 5697-5705, 2012 | 658 | 2012 |
| Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells P Kebriaei, H Singh, MH Huls, MJ Figliola, R Bassett, S Olivares, B Jena, ... The Journal of clinical investigation 126 (9), 3363-3376, 2016 | 531 | 2016 |
| New insights to the MLL recombinome of acute leukemias C Meyer, E Kowarz, J Hofmann, A Renneville, J Zuna, J Trka, ... Leukemia 23 (8), 1490-1499, 2009 | 517 | 2009 |
| Tuning sensitivity of CAR to EGFR density limits recognition of normal tissue while maintaining potent antitumor activity HG Caruso, LV Hurton, A Najjar, D Rushworth, S Ang, S Olivares, T Mi, ... Cancer research 75 (17), 3505-3518, 2015 | 417 | 2015 |
| Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells LV Hurton, H Singh, AM Najjar, KC Switzer, T Mi, S Maiti, S Olivares, ... Proceedings of the National Academy of Sciences 113 (48), E7788-E7797, 2016 | 402 | 2016 |
| Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy DA Knorr, Z Ni, D Hermanson, MK Hexum, L Bendzick, LJN Cooper, ... Stem cells translational medicine 2 (4), 274-283, 2013 | 369 | 2013 |
| Toward eliminating HLA class I expression to generate universal cells from allogeneic donors H Torikai, A Reik, F Soldner, EH Warren, C Yuen, Y Zhou, DL Crossland, ... Blood, The Journal of the American Society of Hematology 122 (8), 1341-1349, 2013 | 353 | 2013 |
| Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation SO Ciurea, JR Schafer, R Bassett, CJ Denman, K Cao, D Willis, ... Blood, The Journal of the American Society of Hematology 130 (16), 1857-1868, 2017 | 331 | 2017 |
| T cells redirected to EphA2 for the immunotherapy of glioblastoma KKH Chow, S Naik, S Kakarla, VS Brawley, DR Shaffer, Z Yi, N Rainusso, ... Molecular Therapy 21 (3), 629-637, 2013 | 272 | 2013 |
| Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen–matched unrelated and … A Di Stasi, DR Milton, LM Poon, A Hamdi, G Rondon, J Chen, SR Pingali, ... Biology of Blood and Marrow Transplantation 20 (12), 1975-1981, 2014 | 254 | 2014 |
| Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies H Singh, MJ Figliola, MJ Dawson, H Huls, S Olivares, K Switzer, T Mi, ... Cancer research 71 (10), 3516-3527, 2011 | 233 | 2011 |
| Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cells H Singh, MJ Figliola, MJ Dawson, S Olivares, L Zhang, G Yang, S Maiti, ... PloS one 8 (5), e64138, 2013 | 216 | 2013 |
| Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity N Shah, B Martin-Antonio, H Yang, S Ku, DA Lee, LJN Cooper, ... PloS one 8 (10), e76781, 2013 | 207 | 2013 |
| Expansion, purification, and functional assessment of human peripheral blood NK cells SS Somanchi, VV Senyukov, CJ Denman, DA Lee JoVE (Journal of Visualized Experiments), e2540, 2011 | 206 | 2011 |
| Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection PR Kumaresan, PR Manuri, ND Albert, S Maiti, H Singh, T Mi, J Roszik, ... Proceedings of the National Academy of Sciences 111 (29), 10660-10665, 2014 | 196 | 2014 |
| Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children CS Cox Jr, JE Baumgartner, MT Harting, LL Worth, PA Walker, SK Shah, ... Neurosurgery 68 (3), 588-600, 2011 | 193 | 2011 |
| Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptor DC Deniger, K Switzer, T Mi, S Maiti, L Hurton, H Singh, H Huls, ... Molecular therapy 21 (3), 638-647, 2013 | 184 | 2013 |
| Phase I study of cord blood‐derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma N Shah, L Li, J McCarty, I Kaur, E Yvon, H Shaim, M Muftuoglu, E Liu, ... British journal of haematology 177 (3), 457-466, 2017 | 183 | 2017 |
Sourindra MaitiM.D. Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证
